1. Home
  2. PHAT vs STAA Comparison

PHAT vs STAA Comparison

Compare PHAT & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Phathom Pharmaceuticals Inc.

PHAT

Phathom Pharmaceuticals Inc.

HOLD

Current Price

$9.62

Market Cap

894.0M

Sector

Health Care

ML Signal

HOLD

Logo STAAR Surgical Company

STAA

STAAR Surgical Company

HOLD

Current Price

$29.78

Market Cap

867.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PHAT
STAA
Founded
2018
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Ophthalmic Goods
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
894.0M
867.9M
IPO Year
2019
1995

Fundamental Metrics

Financial Performance
Metric
PHAT
STAA
Price
$9.62
$29.78
Analyst Decision
Strong Buy
Buy
Analyst Count
6
9
Target Price
$19.83
$22.81
AVG Volume (30 Days)
1.2M
965.6K
Earning Date
04-30-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
42.72
N/A
EPS
N/A
0.10
Revenue
$175,110,000.00
$239,442,000.00
Revenue This Year
$93.04
$30.82
Revenue Next Year
$58.91
$8.41
P/E Ratio
N/A
$292.50
Revenue Growth
216.93
N/A
52 Week Low
$4.25
$15.59
52 Week High
$18.31
$35.87

Technical Indicators

Market Signals
Indicator
PHAT
STAA
Relative Strength Index (RSI) 31.78 53.77
Support Level N/A $23.75
Resistance Level $12.83 $35.87
Average True Range (ATR) 0.72 1.69
MACD -0.26 -0.39
Stochastic Oscillator 2.57 35.16

Price Performance

Historical Comparison
PHAT
STAA

About PHAT Phathom Pharmaceuticals Inc.

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.

About STAA STAAR Surgical Company

Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.

Share on Social Networks: